Glaxosmithkline Pharmaceuticals Ltd NSE  /  BSE

Pharmaceuticals, Mid Cap

29 Sep 2020 | 03:59 PM

1,572.65
-4.25 (-0.27%)

  • Underperforms Index

    13.33%

    Return (1Y)

    Underperformed S&P BSE Healthcare by 45.45%

  • More Volatile

    2.17%

    Standard Deviation (1Y)

    Higher than S&P BSE Healthcare by 0.51%

  • Not so consistent

    4/12

    Months

    underperformed S&P BSE Healthcare

  • AxisDirect View

    No View

52 Week High-Low

1,805

1,805.00

1,046

1,046.40

News & Announcements

Price vs Volume

Stock Trivia

  • FII shareholding in Glaxosmithkline Pharma Ltd has decreased by -23.37% since past 3 Months

  • MF shareholding in Glaxosmithkline Pharma Ltd has increased by 4.29% since past 3 Months

  • FII shareholding in Glaxosmithkline Pharma Ltd has decreased by -82.89% since past 1 Year

  • MF shareholding in Glaxosmithkline Pharma Ltd has increased by 60.4% since past 1 Year

Loading...